Authors:
GREEN LJ
MARDER P
UM SL
JAKUBOWSKI JA
LAWRENCE JB
Citation: Lj. Green et al., QUANTITATIVE DETECTION OF PLATELET GPIIB-IIIA RECEPTOR ANTAGONIST ACTIVITY USING A FLOW CYTOMETRIC METHOD, Journal of clinical laboratory analysis, 12(4), 1998, pp. 191-196
Authors:
TONKINSON JL
MARDER P
ANDIS SL
SCHULTZ RM
GOSSETT LS
SHIH C
MENDELSOHN LG
Citation: Jl. Tonkinson et al., CELL-CYCLE EFFECTS OF ANTIFOLATE ANTIMETABOLITES - IMPLICATIONS FOR CYTOTOXICITY AND CYTOSTASIS, Cancer chemotherapy and pharmacology, 39(6), 1997, pp. 521-531
Authors:
VANPELT JPA
DEJONG EMGJ
VANERP PEJ
MITCHELL MI
MARDER P
SPAETHE SM
VANHOOIJDONK CAEM
KUIJPERS ALA
VANDEKERKHOF PCM
Citation: Jpa. Vanpelt et al., THE REGULATION OF CD11B INTEGRIN LEVELS ON HUMAN BLOOD LEUKOCYTES ANDLEUKOTRIENE B4-STIMULATED SKIN BY A SPECIFIC LEUKOTRIENE B4 RECEPTOR ANTAGONIST (LY293111), Biochemical pharmacology, 53(7), 1997, pp. 1005-1012
Authors:
MARDER P
GREEN LJ
UM SL
JAKUBOWSKI JA
LAWRENCE JB
Citation: P. Marder et al., ANALYSIS OF FIBRINOGEN BINDING TO PLATELETS AND QUANTITATIVE DETECTION OF PLATELET IIB IIIA RECEPTOR ANTAGONIST ACTIVITY USING FLOW CYTOMETRIC METHODS/, Molecular biology of the cell, 7, 1996, pp. 1437-1437
Citation: Ec. Oleary et al., GLUCOCORTICOID EFFECTS IN AN ENDOTOXIN-INDUCED RAT PULMONARY INFLAMMATION MODEL - DIFFERENTIAL-EFFECTS ON NEUTROPHIL INFLUX, INTEGRIN EXPRESSION, AND INFLAMMATORY MEDIATORS, American journal of respiratory cell and molecular biology, 15(1), 1996, pp. 97-106
Citation: N. Falla et al., ANABOLIC INTERMITTENT TREATMENT WITH HPTH-1-34 SELECTIVELY UP-REGULATES MULTIPLE GROWTH-FACTOR RECEPTORS IN CELLS OF THE METAPHYSEAL BUT NOT DIAPHYSEAL MARROW OF YOUNG-RATS, Journal of bone and mineral research, 11, 1996, pp. 470-470
Authors:
MARDER P
SPAETHE SM
FROELICH LL
CERIMELE BJ
PETERSEN BH
TANNER T
LUCAS RA
Citation: P. Marder et al., INHIBITION OF EX-VIVO NEUTROPHIL ACTIVATION BY ORAL LY293111, A NOVELLEUKOTRIENE B-4 RECEPTOR ANTAGONIST, British journal of clinical pharmacology, 42(4), 1996, pp. 457-464
Authors:
ALLEN DL
HOFFMAN WP
MARDER P
MATCHETT MR
LEITER PA
ABBOTT DL
WOLFF RK
Citation: Dl. Allen et al., THE EFFECTS OF LY293111NA, A LEUKOTRIENE B-4 RECEPTOR ANTAGONIST, ON THE PULMONARY NEUTROPHILIA AND CD11B EXPRESSION CAUSED BY INHALATION OF A LEUKOTRIENE B-4 AEROSOL IN RHESUS-MONKEYS, The Journal of pharmacology and experimental therapeutics, 277(1), 1996, pp. 341-349
Authors:
SOFIA MJ
NELSON K
HERRON DK
GOODSON T
FROELICH LL
SPAETHE SM
MARDER P
ROMAN CR
FLEISCH JH
Citation: Mj. Sofia et al., L-5-[6-METHYL-6-(2H-TETRAZOL-5-YL)HEPTYLOXY]PHENOL LEUKOTRIENE B-4 RECEPTOR ANTAGONISTS, Bioorganic & medicinal chemistry letters, 5(17), 1995, pp. 1995-2000
Authors:
MARDER P
REIDY C
ANGLETON E
SHUMAN R
CAMPBELL C
HUI KY
Citation: P. Marder et al., THROMBIN RECEPTOR RECEPTOR ANTAGONISTS DIFFERENTIALLY INHIBIT ACTIVATION FUNCTIONS OF HUMAN PLATELETS, The FASEB journal, 9(3), 1995, pp. 563-563
Authors:
SAWYER JS
BACH NJ
BAKER SR
BALDWIN RF
BORROMEO PS
COCKERHAM SL
FLEISCH JH
FLOREANCIG P
FROELICH LL
JACKSON WT
MARDER P
PALKOWITZ JA
ROMAN CR
SAUSSY DL
SCHMITTLING EA
SILBAUGH SA
SPAETHE SM
STENGEL PW
SOFIA MJ
Citation: Js. Sawyer et al., SYNTHETIC AND STRUCTURE-ACTIVITY STUDIES ON ACID-SUBSTITUTED 2-ARYLPHENOLS - DISCOVERY OF OPHENYL)-5-HYDROXYPHENOXY]-PROPOXY]PHENOXY]BENZOIC ACID, A HIGH-AFFINITY LEUKOTRIENE B-4 RECEPTOR ANTAGONIST, Journal of medicinal chemistry, 38(22), 1995, pp. 4411-4432
Authors:
VLAHOS CJ
MATTER WF
BROWN RF
TRAYNORKAPLAN AE
HEYWORTH PG
PROSSNITZ ER
YE RD
MARDER P
SCHELM JA
ROTHFUSS KJ
SERLIN BS
SIMPSON PJ
Citation: Cj. Vlahos et al., INVESTIGATION OF NEUTROPHIL SIGNAL-TRANSDUCTION USING A SPECIFIC INHIBITOR OF PHOSPHATIDYLINOSITOL 3-KINASE, The Journal of immunology, 154(5), 1995, pp. 2413-2422
Authors:
MARDER P
SAWYER JS
FROELICH LL
MANN LL
SPAETHE SM
Citation: P. Marder et al., BLOCKADE OF HUMAN NEUTROPHIL ACTIVATION BY ROPHENYL)-5-HYDROXYPHENOXY]PROPOXY]PHENOXY]BENZOIC ACID (LY293111), A NOVEL LEUKOTRIENE B-4 RECEPTOR ANTAGONIST, Biochemical pharmacology, 49(11), 1995, pp. 1683-1690
Authors:
MOHAMADI F
SPEES MM
STATEN GS
MARDER P
KIPKA JK
JOHNSON DA
BOGER DL
ZARRINMAYEH H
Citation: F. Mohamadi et al., TOTAL SYNTHESIS AND BIOLOGICAL PROPERTIES OF NOVEL ANTINEOPLASTIC (CHLOROMETHYL)FURANOINDOLINES - AN ASYMMETRIC HYDROBORATION MEDIATED SYNTHESIS OF THE ALKYLATION SUBUNITS, Journal of medicinal chemistry, 37(2), 1994, pp. 232-239
Authors:
SOFIA MJ
FLOREANCIG P
JACKSON WT
MARDER P
SAUSSY DL
SILBAUGH SA
COCKERHAM SL
FROELICH LL
ROMAN CR
STENGEL PW
FLEISCH JH
Citation: Mj. Sofia et al., ACID UNIT MODIFICATIONS OF 1,2,4,5-SUBSTITUTED HYDROXYACETOPHENONES AND THE EFFECT ON INVITRO AND INVIVO LTB(4) RECEPTOR ANTAGONISM, Bioorganic & medicinal chemistry letters, 3(6), 1993, pp. 1147-1152
Authors:
SOFIA MJ
FLOREANCIG P
BACH NJ
BAKER SR
COCKERHAM SL
FLEISCH JH
FROELICH LL
JACKSON WT
MARDER P
ROMAN CR
SAUSSY DL
SPAETHE SM
STENGEL PW
SILBAUGH SA
Citation: Mj. Sofia et al., O-PHENYLPHENOLS - POTENT AND ORALLY-ACTIVE LEUKOTRIENE B-4 RECEPTOR ANTAGONISTS, Journal of medicinal chemistry, 36(24), 1993, pp. 3978-3981
Citation: P. Marder, LIGAND INTERACTIONS WITH THE RGD RECOGNITION SITE ALTER BINDING OF GPIIB-IIIA REACTIVE MONOCLONAL-ANTIBODY TO HUMAN PLATELETS, Biochemical and biophysical research communications, 195(2), 1993, pp. 799-806